The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
A pharma industry veteran with over three decades of experience in domestic as well as international markets
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) Ltd. located at Gifford House, Slaidburn Crescent, Southport, UK
He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
Subscribe To Our Newsletter & Stay Updated
